Health‐related quality of life (HRQoL) · heart transplant recipients
1 finding from 1 review
Exercise capacity · heart transplant recipients
1 finding from 1 review
Health‐related quality of life · heart transplant recipients
1 finding from 1 review
All‐cause mortality maximum · patients with acute coronary syndrome
Drug‐eluting stents showed no clear difference in all‐cause mortality at maximum compared with bare‐metal stents (low certainty).
1 finding from 1 review
Serious adverse events maximum · patients with acute coronary syndrome
Drug‐eluting stents may leads to lower serious adverse events at maximum compared with bare‐metal stents (low certainty).
1 finding from 1 review
Major cardiovascular event Physicians · patients with acute coronary syndrome
It is very uncertain whether drug‐eluting stents changes major cardiovascular events at maximum compared with bare‐metal stents (very low certainty).
1 finding from 1 review
Quality of life at maximum · patients with acute coronary syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality · patients with acute coronary syndrome
It is very uncertain whether drug‐eluting stents changes cardiovascular mortality at maximum compared with bare‐metal stents (very low certainty).
1 finding from 1 review
Myocardial infarction · patients with acute coronary syndrome
It is very uncertain whether drug‐eluting stents changes myocardial infarction at maximum compared with bare‐metal stents (very low certainty).
1 finding from 1 review
Angina · patients with acute coronary syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in all‐cause mortality compared with aspirin (moderate certainty).
1 finding from 1 review
Non‐fatal cardiovascular events · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in non‐fatal cardiovascular events (non‐fatal stroke, myocardial… compared with aspirin (moderate certainty).
1 finding from 1 review
Major bleeding · patients with heart failure with sinus rhythm
Summary of findings: warfarin probably leads to higher major bleeding events compared with aspirin (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in all‐cause mortality compared with clopidogrel (low certainty).
1 finding from 1 review
Non‐fatal cardiovascular events · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in non‐fatal cardiovascular events (non‐fatal stroke, myocardial… compared with clopidogrel (low certainty).
1 finding from 1 review
Major bleeding · patients with heart failure with sinus rhythm
Summary of findings: warfarin may leads to higher major bleeding events compared with clopidogrel (low certainty).
1 finding from 1 review
Thromboembolic events · Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment
Self‐monitoring or self‐management of oral anticoagulation probably leads to lower thromboembolic events compared with standard care (moderate certainty).
1 finding from 1 review
All‐cause mortality · Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment
self‐management of oral anticoagulation probably leads to lower all‐cause mortality compared with standard care (moderate certainty).
1 finding from 1 review
Major bleeding · Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment
self‐management of oral anticoagulation showed no clear difference in major haemorrhage compared with standard care (low certainty).
1 finding from 1 review
Minor haemorrhage · Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment
self‐management of oral anticoagulation showed no clear difference in minor haemorrhage compared with standard care (low certainty).
1 finding from 1 review